In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains-Reference-Cited by-同舟云学术

In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains

Published:2018-02-12 Issue:5 Volume:73 Page:1291-1294
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Damião Gouveia A C¹,Unemo M²,Jensen J S¹^ORCID

Affiliation:

1. Research Unit for Reproductive Tract Microbiology, Statens Serum Institut, Copenhagen, Denmark

2. WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden

Funder

Kongelig Hofbundtmager Aage Bangs Fond

WHO

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/5/1291/24610125/dky022.pdf

Reference26 articles.

1. Mycoplasma genitalium: from chrysalis to multicolored butterfly;Taylor-Robinson;Clin Microbiol Rev,2011

2. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains;Jensen;Antimicrob Agents Chemother,2014